Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase.


Group B streptococci (GBS; Streptococcus agalactiae) are a major cause of invasive infections in newborn infants and in patients with type 2 diabetes. Both patient groups exhibit peripheral insulin resistance and alterations in polymorphonuclear leukocyte (PML) function. In this investigation, we studied the PML response repertoire to GBS with a focus on TLR signaling and the modulation of this response by insulin in mice and humans. We found that GBS-induced, MyD88-dependent chemokine formation of PML was specifically downmodulated by insulin via insulin receptor-mediated induction of PI3K. PI3K inhibited transcription of chemokine genes on the level of NF-κB activation and binding. Insulin specifically modulated the chemokine response of PML to whole bacteria, but affected neither activation by purified TLR agonists nor antimicrobial properties, such as migration, phagocytosis, bacterial killing, and formation of reactive oxygen species. The targeted modulation of bacteria-induced chemokine formation by insulin via PI3K may form a basis for the development of novel targets of adjunctive sepsis therapy.

DOI: 10.4049/jimmunol.1200205

6 Figures and Tables

Cite this paper

@article{Kenzel2012InsulinMT, title={Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase.}, author={Sybille Kenzel and Miriam Mergen and Julius von S{\"{u}\sskind-Schwendi and Julia Wennekamp and Sachin D. Deshmukh and Monika Haeffner and Antigoni Triantafyllopoulou and Sebastian Fuchs and Susan Farmand and Sandra Santos-Sierra and Jochen Rainer Seufert and Timo K van den Berg and Taco Willem Kuijpers and Philipp Henneke}, journal={Journal of immunology}, year={2012}, volume={189 9}, pages={4582-91} }